Castellino P, Luzi L, Simonson D C, Haymond M, DeFronzo R A
Division of Endocrinology/Diabetes, Yale University School of Medicine, New Haven, Connecticut 06510.
J Clin Invest. 1987 Dec;80(6):1784-93. doi: 10.1172/JCI113272.
We examined the effect of insulin and plasma amino acid concentrations on leucine kinetics in 15 healthy volunteers (age 22 +/- 2 yr) using the euglycemic insulin clamp technique and an infusion of [1-14C]leucine. Four different experimental conditions were examined: (a) study one, high insulin with reduced plasma amino acid concentrations; (b) study two, high insulin with maintenance of basal plasma amino acid concentrations; (c) study three, high insulin with elevated plasma amino acid concentrations; and (d) study four, basal insulin with elevated plasma amino acid concentrations. Data were analyzed using both the plasma leucine and alpha-ketoisocaproate (the alpha-ketoacid of leucine) specific activities. In study one total leucine flux, leucine oxidation, and nonoxidative leucine disposal (an index of whole body protein synthesis) all decreased (P less than 0.01) regardless of the isotope model utilized. In study two leucine flux did not change, while leucine oxidation increased (P less than 0.01) and nonoxidative leucine disposal was maintained at the basal rate; endogenous leucine flux (an index of whole body protein degradation) decreased (P less than 0.01). In study three total leucine flux, leucine oxidation, and nonoxidative leucine disposal all increased significantly (P less than 0.01). In study four total leucine flux, leucine oxidation, and nonoxidative leucine disposal all increased (P less than 0.001), while endogenous leucine flux decreased (P less than 0.001). We conclude that: (a) hyperinsulinemia alone decreases plasma leucine concentration and inhibits endogenous leucine flux (protein breakdown), leucine oxidation, and nonoxidative leucine disposal (protein synthesis); (b) hyperaminoacidemia, whether in combination with hyperinsulinemia or with maintained basal insulin levels decreases endogenous leucine flux and stimulates both leucine oxidation and nonoxidative leucine disposal.
我们采用正常血糖胰岛素钳夹技术并输注[1-¹⁴C]亮氨酸,研究了胰岛素和血浆氨基酸浓度对15名健康志愿者(年龄22±2岁)亮氨酸动力学的影响。研究了四种不同的实验条件:(a)研究一,高胰岛素且血浆氨基酸浓度降低;(b)研究二,高胰岛素且维持基础血浆氨基酸浓度;(c)研究三,高胰岛素且血浆氨基酸浓度升高;(d)研究四,基础胰岛素且血浆氨基酸浓度升高。使用血浆亮氨酸和α-酮异己酸(亮氨酸的α-酮酸)比活性对数据进行分析。在研究一中,无论使用何种同位素模型,总亮氨酸通量、亮氨酸氧化和非氧化亮氨酸处置(全身蛋白质合成指标)均下降(P<0.01)。在研究二中,亮氨酸通量未改变,而亮氨酸氧化增加(P<0.01),非氧化亮氨酸处置维持在基础速率;内源性亮氨酸通量(全身蛋白质降解指标)下降(P<0.01)。在研究三中,总亮氨酸通量、亮氨酸氧化和非氧化亮氨酸处置均显著增加(P<0.01)。在研究四中,总亮氨酸通量、亮氨酸氧化和非氧化亮氨酸处置均增加(P<0.001),而内源性亮氨酸通量下降(P<0.001)。我们得出结论:(a)单独的高胰岛素血症会降低血浆亮氨酸浓度并抑制内源性亮氨酸通量(蛋白质分解)、亮氨酸氧化和非氧化亮氨酸处置(蛋白质合成);(b)高氨基酸血症,无论与高胰岛素血症联合还是与维持基础胰岛素水平联合,都会降低内源性亮氨酸通量并刺激亮氨酸氧化和非氧化亮氨酸处置。